Gonadotrophin replacement for induction of fertility in hypogonadal men

被引：72
|
作者：
Dwyer, Andrew A. [1 ]
Raivio, Taneli [2 ,3 ]
Pitteloud, Nelly [1 ,4 ]
机构：
[1] CHU Vaudois, Endocrinol Diabet & Metab Serv, CH-1011 Lausanne, Switzerland
[2] Univ Helsinki, Inst Biomed Physiol, Helsinki, Finland
[3] Helsinki Univ Cent Hosp, Childrens Hosp, Helsinki, Finland
[4] Univ Lausanne, Fac Biol & Med, CHU Vaudois, Inst Physiol & Endocrinol,Diabet & Metab Serv, CH-1011 Lausanne, Switzerland
来源：
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM | 2015年 / 29卷 / 01期
关键词：
GnRH deficiency; Kallmann syndrome; hypogonadotrophic hypogonadism; male fertility; gonadotrophin therapy; fertility treatment; fertility outcomes; HUMAN CHORIONIC-GONADOTROPIN; FOLLICLE-STIMULATING-HORMONE; INTRACYTOPLASMIC SPERM INJECTION; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT HUMAN FSH; ANTIMULLERIAN HORMONE; LUTEINIZING-HORMONE; KALLMANN-SYNDROME; MALE-INFERTILITY; AZOOSPERMIC MEN;
D O I：
10.1016/j.beem.2014.10.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Congenital hypogonadotrophic hypogonadism (CHH) is a rare form of infertility caused by deficient secretion or action of gonadotrophin-releasing hormone. There is no consensus regarding the optimal approach to fertility treatment in CHH men. In most cases, appropriate hormonal treatment with human chorionic gonadotrophin with or without follicle stimulating hormone will induce testicular development, spermatogenesis and fertility. Recent studies have examined sequential treatment with FSH pretreatment to optimize fertility outcomes in severely affected CHH patients. This paper reviews historical and recent literature to summarize the current evidence on therapeutic approaches for CHH men seeking fertility. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码：91 / 103
页数：13
相关论文
共 50 条
  • [41] Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy
    Bernini, G
    Versari, D
    Moretti, A
    Cipriano, A
    Virdis, A
    Ghiadoni, L
    Bardini, M
    Taurino, C
    Taddei, S
    Salvetti, A
    JOURNAL OF HYPERTENSION, 2005, 23 : S211 - S211
  • [42] Testosterone replacement therapy improves erythrocyte membrane lipid composition in hypogonadal men
    Angelova, Petya
    Momchilova, Albena
    Petkova, Diana
    Staneva, Galya
    Pankov, Roumen
    Kamenov, Zdravko
    AGING MALE, 2012, 15 (03): : 173 - 179
  • [43] Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy
    Bernini, G
    Versari, D
    Moretti, A
    Virdis, A
    Ghiadoni, L
    Bardini, M
    Taurino, C
    Canale, D
    Taddei, S
    Salvetti, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (05): : 1691 - 1697
  • [44] The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men
    Malkin, CJ
    Pugh, PJ
    Jones, RD
    Kapoor, D
    Channer, KS
    Jones, TH
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07): : 3313 - 3318
  • [45] TESTOSTERONE REPLACEMENT THERAPY IN HYPOGONADAL MEN UNDERGOING ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Berookhim, B.
    Krishnan, R.
    Nelson, C. J.
    Mulhall, J. P.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 147 - 148
  • [46] ANDROGENS, BEHAVIOR AND NOCTURNAL ERECTION IN HYPOGONADAL MEN - THE EFFECTS OF VARYING THE REPLACEMENT DOSE
    OCARROLL, R
    SHAPIRO, C
    BANCROFT, J
    CLINICAL ENDOCRINOLOGY, 1985, 23 (05) : 527 - 538
  • [47] Racial Differences in Hypogonadal Improvement and Prostate-Specific Antigen Levels in Hypogonadal Men Treated With Testosterone Replacement Therapy
    Coward, Robert M.
    Simhan, Jay
    Carson, Culley C., III
    INTERNATIONAL BRAZ J UROL, 2010, 36 (06): : 700 - 707
  • [48] Testosterone replacement therapy in hypogonadal men: Assessing benefits, risks, and best practices
    Miner, Martin
    Canty, David J.
    Shabsigh, Ridwan
    POSTGRADUATE MEDICINE, 2008, 120 (03) : 130 - 153
  • [49] Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism
    Pencina, Karol M.
    Travison, Thomas G.
    Cunningham, Glenn R.
    Lincoff, A. Michael
    Nissen, Steven E.
    Khera, Mohit
    Miller, Michael G.
    Flevaris, Panagiotis
    Li, Xue
    Wannemuehler, Kathleen
    Bhasin, Shalender
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (02): : 569 - 580
  • [50] Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life
    Malkin, CJ
    Pugh, PJ
    Morris, PD
    Kerry, KE
    Jones, RD
    Jones, TH
    Channer, KS
    HEART, 2004, 90 (08) : 871 - 876
12345